YD-19
| Product Name | YD-19 |
|---|---|
| Alternate Names | - Impurities, Impurities of - |
| CAT No. | CS-O-43814 |
| CAS No. | 2068709-68-0 |
| Category | Impurities |
| Stock | Enquire |
| Mol. Wt. | 560.35 g/mol |
| Mol. For. | C25H15Cl2N9O3 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | - |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Get an Instant Quote
Related Compounds
N-Nitroso N-Desmethyl Mianserin | Chlorthalidone amide impurity | Nandrolone caproate | Chlordiazepoxide oxaziridine | trimethylsulfonium p-toluenesulfonate (TMSI) | n-Decyl-d21-trimethylammonium Bromide | Sugammadex sodium impurity 50 | Sacubitril Impurity 57 | Nimodipine Impurity 6 | Larotrectinib (3S,2S) Sulfate | Nandrolone cypionate | N-nitroso-N-phenethyl acetamide | Piperacillin Impurity I | Enzalutamide n-Acetyl impurity | Fmoc-Val-Ser[Psi(Me,Me)Pro]-OH | N-phenyl-N-(3-(trifluoromethyl)phenyl)nitrous amide | Heptacarboxylporphyrin I Dihydrochloride | Lumefantrine Hydroxy impurity (Mixture of Isomers) | Cyclotrimethylenetriamine | Bis-anhydro-Daunomycinone Carboxylic Acid | Methyl 1-[2-(dimethylamino)ethyl]-3-piperidinecarboxylate | Benzyl (3R,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate | Sugammadex vinyl impurity | Ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1,2-dimethyl-1H-indole-3-carboxylate | Diethyl P-(2-cyclopropyl-2-oxoethyl) phosphonate | Valsartan Desvaleryl Methyl Ester | midazolam N-Nitroso N-Oxide Nitromethylene Impurity | Phytonadione (S) Hydroxy impurity | N-benzyl diclofenac | N'-(2-((5-chloro-2-nitrophenyl)thio)phenyl)-2-(pyrrolidin-1-yl)acetohydrazide | Samidorphan isoquinoline dioxolane | Ceftriaxone 3-ene Isomer Disodium Salt | N-(4-hydroxybutyl)-N-isopropylnitrous amide | N-Nitroso Silodosin Nitrile Impurity | N-Nitroso Vilazodone Impurity 3 | Atracurium cis-trans isomer | Ethyl Methyl Sulfide | D-Cysteine Methyl Ester | Lithium ((3-(methacryloyloxy)propyl)sulfonyl)((trifluoromethyl)sulfonyl)amide | Zanubrutinib Mesyl impurity | Resmetirom Impurity 1 | Sacubitril Impurity 14 | N,N-bis(7-methyloctyl)nitrous amide | PEG-8 Laurate | Gamma-glutamyl-2-naphthylamide | Salmeterol Related Compound H | Deformyl Formoterol Citric acid adduct | dCBP-1 | Adrenalin Nitroso Impurity 1 | Cadmium Hydroxide | Nu-chek mix 19A impurity | Malvidin-3-(p-coumaroyl)-rutinoside-5-glucoside | Sorafenib Impurity 16 | N-Lauroyl-N-methyltaurine sodium salt | Ulinastatin JP Reference standard (3700 units) | Cephalosporanic acid G | Efavirenz Descarbonyl Benzyl impurity | Larotrectinib Urea dimer impurity | TBDMS Vitamin | Bolandiol dipropionate | Ethyl 3-(dimethyl amino)-2-butenoate | Diethoxyethane | Maleic anhydride-styrene copolymer | Umeclidinium Bromide Impurity 15 | methyl (1S,2S,5R)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate | N-propyl cyclooct-2-en-1-amine | N-Nitroso-N-Propyl-Sulfamide | N-Nitroso-(S,S)-ethylenediamine-N,N'-disuccinic acid | methyl 4-((5-(4-nitrobenzoyl)-1H-indol-1-yl)methyl)benzoate | Methoxy polyethylene glycol succinate N-hydroxy succinimide |
